Seeking Alpha

Seeking Alpha Portfolio App for iPad

This Market Current was sent to 371 people who get email alerts on GSXN.OB.

Get email alerts on GSXN.OB »

Market Currents

Unlike many pharmaceutical deals, which often deliver little, if any, value as anticipated new...

Monday, April 20, 2009, 3:34 PM ET
Unlike many pharmaceutical deals, which often deliver little, if any, value as anticipated new treatments fail to materialize, Glaxo's (GSX) Stiefel acquisition looks likely to make money for shareholders. GSK -1.7%.

This Market Current was sent to 371 people who get email alerts on GSXN.OB.

Get email alerts on GSXN.OB »

Share this Market Current

Short URL:

Other date

DJIA (DIA) S&P 500 (SPY)

Latest Articles

Restoring Trust In Finance: Remember That 'It's Always Someone Else's Money'
3:49 AM • CFA Institute Contributors
Under-Reported Aspects Of The S&P 500 Rally
3:43 AM • Marc Chandler
It's Time To Stop Fed Central Planning
3:42 AM • Thomas J. Feeney
Higher Bond Yields Suggest Abenomics Is Working (But Only A Little)
3:36 AM • Scott Sumner
Poised To Triple: Portfolio Update
3:32 AM • Mark Gomes
Thoughts On Stock Splits
3:30 AM • David Merkel
What The News Corp. Split Means For Investors
3:25 AM • Gary Bourgeault
Looking At A Growing Labor Shortage?
3:14 AM • Steven Hansen
Unsteady As She Goes
3:00 AM • The Inflation Trader
ConocoPhillips: A Dividend And Total Return Stalwart
2:59 AM • Albert Alfonso
S&P 500 Snapshot: A Fractional Loss Ends A Strange Week
2:57 AM • Doug Short
China Biotech In Review: Hisun-Pfizer, Merck-Simcere JVs Come Into Focus
2:50 AM • ChinaBio Today
Gold Bulls Are Giving Up - Should You?
2:31 AM • Avi Gilburt
Why This Long-Time Bull Is Moving To The Sidelines
2:24 AM • Alan Brochstein
Looking At The Future And Operations Of DryShips
2:20 AM • MTF Investing

More Latest Articles »